Cyclo Therapeutics, Inc. (CYTH)
NASDAQ: CYTH · IEX Real-Time Price · USD
1.200
-0.010 (-0.83%)
At close: Apr 18, 2024, 3:59 PM
1.260
+0.060 (5.00%)
After-hours: Apr 18, 2024, 6:51 PM EDT

Cyclo Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 1995
Net Income
-20.06-15.45-14.29-8.94-7.53-4.26-3.83-4.22-2.55-0.59
Upgrade
Depreciation & Amortization
0.020.020.020.010.010.010.010.110.170.15
Upgrade
Share-Based Compensation
0.740.510.470.270.3600.120.120.070.16
Upgrade
Other Operating Activities
3.12-0.2-1.210.120.581.060.641.040.32-0.35
Upgrade
Operating Cash Flow
-16.19-15.11-15.01-8.54-6.59-3.19-3.06-2.95-1.99-0.63
Upgrade
Capital Expenditures
-0-0.02-0.02-0.05-0-0-00.92-0.42-0.17
Upgrade
Change in Investments
00.050.040.040.040.040.030.0300
Upgrade
Investing Cash Flow
-00.040.01-0.010.040.030.030.94-0.42-0.17
Upgrade
Share Issuance / Repurchase
9.74018.7618.467.124.13.341.881.913.02
Upgrade
Debt Issued / Paid
00.01-0.010.16000-0.75-0.04-0.06
Upgrade
Other Financing Activities
14.15---------0.05
Upgrade
Financing Cash Flow
23.890.0118.7618.627.124.13.341.131.872.92
Upgrade
Net Cash Flow
7.7-15.073.7710.060.570.950.31-0.88-0.542.11
Upgrade
Free Cash Flow
-16.19-15.13-15.03-8.59-6.59-3.19-3.06-2.04-2.41-0.81
Upgrade
Free Cash Flow Margin
-1503.84%-1099.71%-947.67%-951.24%-654.37%-315.52%-247.60%-135.44%-253.35%-51.36%
Upgrade
Free Cash Flow Per Share
-0.99-1.79-2.36-5.37-6.09-3.90-4.25-3.21-4.28-1.59
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).